Allan Rabold

Allan Rabold possesses extensive experience in the pharmaceutical sales industry, currently serving as a retired professional since January 2020, while also working as a Medical Science Liaison for Transdermal Therapeutics since 2012. In this independent contractor role, Allan specializes in educating the medical community about the benefits of transdermal anti-inflammatory and neuropathic pain creams. Previously, Allan was a Multaq Executive Sales Professional at sanofi-aventis from 1998 to 2012, contributing to the launch of the anti-arrhythmic medication Multaq and managing sales for Lovenox and Plavix. Allan holds a Bachelor of Science degree in Secondary Education (Biology) from Penn State University.